Injectable Sustained Release Technology, TheraKine, Ltd.
Description
pulled from site's meta descriptionCEO Interviews 2013, Drug Delivery Company, Technology that would allow any Biological Drug to be formulated for Months of Stability and Controlled Release, delivered locally by placing the Drug in the Target Organ or in a Bolus for Systemic Delivers
Domain Resolution
This domain resolves to the following IP addresses:This is an automatically generated AboutUs page for Ceocfostockwatch.com. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
Categories:
- AboutUs AutoGen
- Recent CEO Interviews
- Drug Delivery Stock
- Healthcare Stocks
- tunable
- targeted drug delivery technology for injectable drugs
- sustained release technologies
- custom tunable formulations with weeks to months of predictable release
- tunable release
- able to satisfy any therapeutic need - linear
- burst release
- and decay release can be combined if required
- technologies validated with monoclonal antibodies
- antibody fragments
- receptor antagonists
- and other large molecule drugs as well as class small molecules
- TheraKine
- Ltd. Press Releases
- News
- Companies looking for venture capital
- Angel Investors
- private companies looking for investors
- healthcare companies seeking investors
- drug delivery companies needing investment capital